May 12, 2023
Fusion Pharmaceuticals Announces First Quarter 2023 Financial Results And Clinical Program Updates
Media
May 12, 2023
Carisma Therapeutics Reports First Quarter 2023 Financial Results and Provides Business Highlights
May 11, 2023
Oncopeptides presents new data at the European Haematology Association meeting
May 11, 2023
UCB and Ariceum Therapeutics sign a Strategic Research Collaboration to Discover New Modalities for the Treatment of Immune-related Diseases and Cancer
May 10, 2023
100% limb salvage rate in complex diabetic foot cases with CERAMENT® G/V – study from King’s College Hospital, London
May 04, 2023
Interim Report January-March 2023
May 04, 2023
Oncopeptides publishes Q1 report 2023
May 03, 2023
Vicore initiates clinical proof-of-concept study of endothelial dysfunction
May 03, 2023
HelloBetter received FDA Breakthrough Device Designation for Digital Therapeutic to treat Panic Disorder
May 03, 2023
Vicore initiates clinical proof-of-concept study of endothelial dysfunction